Understanding stigma and its impact on HIV prevention for people who inject drugs
Intersectional Stigma Experiences, Pre-exposure Prophylaxis (PrEP), and Other Service Use Among People Who Inject Drugs
['FUNDING_CAREER'] · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · NIH-11061399
This study looks at how different kinds of stigma affect people who inject drugs and their ability to access PrEP, a medication that helps prevent HIV, so we can better understand the challenges they face and find ways to improve their healthcare.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEW YORK UNIVERSITY SCHOOL OF MEDICINE (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11061399 on ClinicalTrials.gov |
What this research studies
This research investigates how different types of stigma affect the use of pre-exposure prophylaxis (PrEP) among people who inject drugs (PWID). It aims to identify various sub-populations within PWID who experience unique forms of stigma, which may hinder their access to PrEP and other health services. By examining the intersection of factors such as drug use, race, sexual identity, and poverty, the study seeks to uncover barriers to healthcare that PWID face. The findings could inform strategies to improve PrEP uptake and overall health service access for these individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who inject drugs and may be eligible for PrEP but face stigma in accessing healthcare.
Not a fit: Patients who do not inject drugs or are not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to HIV prevention methods for people who inject drugs, ultimately reducing HIV infection rates.
How similar studies have performed: While there has been limited research specifically on PrEP use among PWID, studies on stigma and healthcare access in other populations suggest that addressing stigma can improve health outcomes.
Where this research is happening
NEW YORK, UNITED STATES
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WALTERS, SUZAN M — NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- Study coordinator: WALTERS, SUZAN M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus